Aloe Polysaccharides

Compound Class	Acetylated polysaccharides — principally acemannan, a β-(1,4)-acetylated polymannose. Not a single molecule
Botanical Source	Aloe barbadensis (Aloe vera; ghritkumari)
Plant Part(s)	Inner leaf gel (parenchyma) — NOT the latex/exudate
Critical Distinction	Aloe gel polysaccharides ≠ aloe latex anthraquinones (aloin). Entirely different fractions with different safety profiles
Typical Standardisation	Acemannan 80%; aloe polysaccharides 40%. Assay method must be specified
Primary Applications	Topical wound healing and mucosal repair; oral-care formulation; cosmetic hydration
Claim Strength (Overview)	Moderate for topical and mucosal applications; Emerging and inconsistent for systemic oral claims
Buy from Herbuno	Acemannan 80% Powder (Aloe Vera Extract) | Standardized Aloe Barbadensis → Aloe Polysaccharides 40% Powder (Aloe Vera Extract) | Standardized Aloe Barbadensis →

Name origin: Acemannan — the principal aloe gel polysaccharide — takes its name from its chemistry: an acetylated polymannan, a β-(1,4)-linked mannose backbone bearing acetyl groups. The degree of acetylation is not incidental; it is widely held to be central to the polymer’s biological activity, which is one reason processing conditions matter so much for this ingredient. Traditional use: Aloe has one of the longest continuous records of any medicinal plant, appearing in the Ebers Papyrus, in Dioscorides, and across Ayurveda (as ghritkumari) — but its traditional record is split, and that split is the most important thing on this page. The inner gel was used topically for burns and wounds; the bitter yellow latex from just beneath the rind was used internally as a powerful purgative. These are two entirely different medicines from one leaf. Critical distinction: Aloe gel polysaccharides and aloe latex anthraquinones (principally aloin) are chemically unrelated fractions with entirely different safety profiles. Aloin carries a distinct regulatory history including a 2002 US FDA ruling on OTC laxative use. A product labelled simply "aloe" tells a buyer almost nothing. Commercial source: Inner-leaf gel of Aloe barbadensis, standardized to acemannan or total aloe polysaccharide content.

---

Evidence for Aloe Polysaccharides Applications

The best-evidenced applications are topical and mucosal, and the mucosal data is the more interesting. A study assessed acemannan, a polysaccharide extracted from Aloe vera, for the treatment of oral aphthous ulceration: after a skin patch test in 100 healthy subjects and a mucosal safety assessment in 50, 180 subjects with recurrent aphthous ulceration were randomised to 0.1% triamcinolone acetonide, 0.5% acemannan in Carbopol, or Carbopol alone, applied three times daily for seven days — concluding that acemannan can be used for treating oral aphthous ulceration in patients wishing to avoid steroids, although effectiveness was not comparable to that of triamcinolone (Bhalang 2013). That final clause is the honest one: better than vehicle, worse than the steroid. Claim strength: Moderate.

The wound-healing evidence is more mixed than aloe’s reputation suggests, and this must be reported. A randomized controlled trial of an acemannan hydrogel wound dressing versus moist saline gauze in 30 patients with pressure ulcers found complete healing of the study ulcer in 19 of 30 subjects (63%) over ten weeks, but with no difference observed in complete healing between the experimental and control groups (odds ratio 0.93) (Thomas 1998). A null result against saline gauze, in an FDA-cleared dressing, is a sobering data point for anyone assuming aloe’s wound reputation rests on strong comparative evidence. Claim strength: Emerging.

The mechanistic work is genuinely interesting and points toward the applications most likely to succeed. Acemannan has been shown to affect bone formation: primary rat bone marrow stromal cells treated with acemannan showed increased DNA synthesis, VEGF and BMP-2 expression, alkaline phosphatase activity, bone sialoprotein and osteopontin expression, and mineralisation, with an acemannan-treated sponge placed in a tooth-extraction socket promoting bone formation in vivo. This growth-factor-inducing, tissue-regenerative profile is coherent with the dental and mucosal applications where acemannan has performed best, and it suggests dentistry as the strongest commercial direction. Claim strength: Emerging.

The gel-versus-latex distinction is the single most consequential fact about aloe as a commercial ingredient, and it is routinely muddled. The inner-leaf gel yields the acetylated polysaccharides documented here. The latex — the bitter yellow exudate immediately beneath the rind — yields anthraquinone glycosides, principally aloin, a stimulant laxative with a distinct safety and regulatory history entirely separate from the gel. Decolourised, aloin-reduced gel material is the standard for ingestible aloe products, and a buyer must specify aloin limits explicitly rather than assuming a "gel" designation guarantees them. Claim strength: High (compositional and regulatory fact).

The standardisation problems documented on the Polysaccharides page in this index apply here with full force, and one aloe-specific issue compounds them. Total-polysaccharide assays measure total carbohydrate and are inflatable with free sugars and added maltodextrin — a documented concern for aloe specifically, where dilute gel is routinely concentrated and where maltodextrin is a common carrier. Furthermore, since the degree of acetylation is held to be central to acemannan’s activity, and since acetyl groups are labile to heat and alkaline pH, an aloe polysaccharide that has been aggressively processed may assay correctly while having lost the structural feature that made it worth buying. Claim strength: Moderate.

---

Dosage & Formulator Specification

Herbuno carries Acemannan 80% powder and Aloe Polysaccharides 40% powder, both standardized from Aloe barbadensis, alongside aloe vera extract powder, organic aloe vera leaf powder, and a water-soluble leaf extract. Herbuno separately carries Aloin 95% — this is the latex anthraquinone fraction, an entirely different material documented on its own page in this index, and it must never be confused with the gel polysaccharides.

Dosing is application-dependent and the topical/mucosal route is where the evidence sits. The oral aphthous ulceration trial used 0.5% acemannan in a Carbopol vehicle applied three times daily for seven days — a topical concentration, not an oral dose. For ingestible applications, dosing rests largely on tradition and on inconsistent trial evidence rather than on a defensible dose-response relationship, and formulators should be candid about that. Given that high-molecular-weight polysaccharides are not absorbed intact, systemic claims for orally administered aloe polysaccharides face the same pharmacokinetic objection documented for LBP and other polysaccharides in this index.

Analytical verification should not stop at a total-polysaccharide percentage. Request the acemannan content specifically, the degree of acetylation (which is held to be central to activity and is labile to heat and alkaline processing), molecular-weight distribution, and free-sugar and maltodextrin content quantified and subtracted. Critically, an explicit aloin limit must be specified and certified for any ingestible material — do not assume that a "gel" or "inner leaf" designation guarantees it. Processing history matters unusually much here: aggressively processed material may assay correctly while having lost the structure that mattered.

Decolourised, aloin-reduced Aloe vera inner-leaf gel has a good safety record in topical and oral-care use and an acceptable one in food and beverage applications at typical intakes; the aphthous-ulcer study included formal skin patch testing and mucosal safety assessment with liver and kidney function monitoring. The dominant safety issue for this ingredient is not the polysaccharide but the potential aloin contamination of inadequately processed gel material: aloin is a stimulant anthraquinone laxative with a distinct regulatory history, and its presence turns a benign gel product into something quite different. Non-decolourised whole-leaf aloe extract has been the subject of specific safety concern and should not be assumed equivalent to purified gel. Aloe latex is contraindicated in pregnancy and in intestinal obstruction.

---

Frequently Asked Questions — Aloe Polysaccharides

What is the difference between aloe gel and aloe latex?
It is the single most consequential fact about aloe, and it is routinely muddled. The inner-leaf gel yields acetylated polysaccharides like acemannan. The latex — the bitter yellow exudate just beneath the rind — yields anthraquinones, principally aloin, a stimulant laxative with an entirely separate safety and regulatory history. A product labelled simply "aloe" tells you almost nothing.

Does acemannan actually heal wounds?
The evidence is more mixed than aloe's reputation suggests. A randomized trial of acemannan hydrogel dressing versus plain saline gauze in 30 pressure-ulcer patients found no difference in complete healing between groups. The mucosal data is stronger — acemannan beat vehicle for oral aphthous ulcers, though it was not as effective as triamcinolone.

Why does the degree of acetylation matter?
Because it is widely held to be central to acemannan's biological activity — and acetyl groups are labile to heat and alkaline pH. This means aggressively processed aloe material may assay correctly for total polysaccharide while having lost the very structural feature that made it worth buying. Processing history matters unusually much here.

What should I demand on the certificate of analysis?
Acemannan content specifically (not just total polysaccharide, which is inflatable with free sugars and maltodextrin), the degree of acetylation, molecular weight distribution, and — critically — an explicit certified aloin limit for any ingestible material. Do not assume a "gel" or "inner leaf" designation guarantees low aloin.

Related compounds: Polysaccharides, LBP Polysaccharides, Beta-Glucans, Inulin

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery